000 03831nam a22003735i 4500
001 277924
003 MX-SnUAN
005 20160429153840.0
007 cr nn 008mamaa
008 150903s2006 xxu| o |||| 0|eng d
020 _a9780387328232
_99780387328232
024 7 _a10.1007/0387328232
_2doi
035 _avtls000330996
039 9 _a201509030727
_bVLOAD
_c201404120556
_dVLOAD
_c201404090336
_dVLOAD
_c201401311359
_dstaff
_y201401301159
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRC321-580
100 1 _aBrundin, Patrik.
_eeditor.
_9301129
245 1 0 _aRestorative Therapies in Parkinson's Disease /
_cedited by Patrik Brundin, C. Warren Olanow.
264 1 _aBoston, MA :
_bSpringer US,
_c2006.
300 _axvii, 365 páginas,
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
500 _aSpringer eBooks
505 0 _aRestorative Therapies in a Historical Perspective -- Ethical Issues in the Approaches of Restorative Therapies for Parkinson's Disease -- Evolution of Parkinson's Disease and Treatment Requirements -- What New Treatments are Needed and the Role of Striatal Grafting -- Clinical Trial Design Issues -- Lessons Learnt from Early Clinical Neural Grafting in Parkinson's Disease -- Fetal Nigral Transplantation as a Therapy for Parkinson’s Disease -- Imaging of the Parkinsonian Brain in Relation to Restorative Therapy -- Important Aspects of Surgical Methodology for Transplantation in Parkinson’s Disease -- Histopathological and Clinical Criteria for Analyzing Transplanted Human Dopamine Cells in Parkinson's Disease -- Dyskinesias and Neural Grafting in Parkinson's Disease -- Porcine Neural Xenotransplantation: Current Status -- Adult-Derived Stem Cells for Transplantation in Parkinson's Disease -- Embryonic Stem Cells for Grafting in Parkinson's Disease -- Delivery of GDNF For Parkinson's Disease: Transition of a Neuroprotective Treatment Strategy from Basic Sciences to Clinical Application -- Genetically Modified Cells as a Source for Grafting in Parkinson'se Disease -- In Vivo Gene Therapy as a Potential Treatment for Parkinson's Disease.
520 _aParkinson’s disease is a common and devastating progressive disorder that primarily affects motor function. In this exciting and timely book, novel approaches to repairing the parkinsonian brain are described by some of the world’s leading scientists and clinicians in the field. Dealing with cutting-edge research, it covers several important topics including medical ethics, clinical trial design, stem cell biology, intracerebral transplantation, brain imaging, neurotrophic factors and neural regeneration. The comprehensive chapters are geared to an audience of neuroscientists, neurologists, neurosurgeons and anyone interested in how findings in the research laboratory can effectively be transferred to the clinic. Restorative therapies in Parkinson’s disease have pioneered translational research in the area of brain repair for close to three decades. This book clearly shows that research in Parkinson’s disease continues to play a leading role and can provide a model for how functional restoration might be achieved in several brain disorders in the future.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aOlanow, C. Warren.
_eeditor.
_9301130
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9780387299846
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/0-387-32823-2
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c277924
_d277924